Cargando…
Metabolic Syndrome Predicts New Onset of Chronic Kidney Disease in 5,829 Patients With Type 2 Diabetes: A 5-year prospective analysis of the Hong Kong Diabetes Registry
OBJECTIVE—Type 2 diabetes is the leading cause of end-stage renal disease worldwide. Aside from hyperglycemia and hypertension, other metabolic factors may determine renal outcome. We examined risk associations of metabolic syndrome with new onset of chronic kidney disease (CKD) in 5,829 Chinese pat...
Autores principales: | Luk, Andrea O.Y., So, Wing-Yee, Ma, Ronald C.W., Kong, Alice P.S., Ozaki, Risa, Ng, Vanessa S.W., Yu, Linda W.L., Lau, Winnie W.Y., Yang, Xilin, Chow, Francis C.C., Chan, Juliana C.N., Tong, Peter C.Y. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2584195/ https://www.ncbi.nlm.nih.gov/pubmed/18835954 http://dx.doi.org/10.2337/dc08-0971 |
Ejemplares similares
-
Low LDL Cholesterol, Albuminuria, and Statins for the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2009) -
Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2010) -
Lipid control and use of lipid-regulating drugs for prevention of cardiovascular events in Chinese type 2 diabetic patients: a prospective cohort study
por: Ting, Rose ZW, et al.
Publicado: (2010) -
Aldose Reductase Genotypes and Cardiorenal Complications: An 8-year prospective analysis of 1,074 type 2 diabetic patients
por: So, Wing-Yee, et al.
Publicado: (2008) -
Validation of Methods to Control for Immortal Time Bias in a Pharmacoepidemiologic Analysis of Renin–Angiotensin System Inhibitors in Type 2 Diabetes
por: Yang, Xilin, et al.
Publicado: (2014)